Phaos Technology Holdings (Cayman) (POAS) Total Debt (2024 - 2025)
Phaos Technology Holdings (Cayman) posted quarterly Total Debt of $81852.0 for Q4 2025, down 18.34% on a QoQ basis from $100230.1 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) has 2 years of Total Debt data on file, last reported at $81852.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Debt changed N/A year-over-year to $81852.0; the trailing twelve-month figure through Oct 2025 stood at $81852.0 (changed N/A YoY), and the FY2025 full-year result was $102628.0, down 75.94% from the prior year.
- Total Debt for Q4 2025 stood at $81852.0, down from $100230.1 in the prior quarter.
- Across five years, Total Debt topped out at $426507.1 in Q2 2024 and bottomed at $81852.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 34.05 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.72 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 28.07 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 11.03 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 598.50 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 8.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.13 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.93 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.83 Mn | 6.73 Mn | - | 81,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 81,852.00 |
| Apr 30, 2025 | 100,230.11 |
| Apr 30, 2024 | 426,507.07 |